EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 208 filers reported holding EXELIXIS INC in Q3 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $437,892 | -45.7% | 27,300 | -46.9% | 0.06% | -60.7% |
| Q3 2022 | $806,000 | -10.4% | 51,400 | +29.4% | 0.16% | +21.6% |
| Q1 2022 | $900,000 | +50.0% | 39,712 | +41.3% | 0.13% | +8.1% |
| Q2 2019 | $600,000 | -66.0% | 28,100 | -62.1% | 0.12% | -63.4% |
| Q1 2019 | $1,766,000 | +16.3% | 74,200 | -3.9% | 0.34% | +9.0% |
| Q4 2018 | $1,519,000 | +107.5% | 77,200 | +86.9% | 0.31% | +159.2% |
| Q3 2018 | $732,000 | +140.0% | 41,300 | +311.9% | 0.12% | +93.5% |
| Q4 2017 | $305,000 | -57.8% | 10,027 | -79.3% | 0.06% | -65.6% |
| Q4 2016 | $723,000 | +162.9% | 48,500 | +125.6% | 0.18% | 0.0% |
| Q3 2016 | $275,000 | +29.7% | 21,500 | -59.4% | 0.18% | -10.0% |
| Q1 2016 | $212,000 | – | 53,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |